Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Molecular Dynamics of Multivalent Soluble Antigen Arrays Support Two-Signal Codelivery Mechanism in Treatment of Experimental Autoimmune Encephalomyelitis.
Where Do AQP4 Antibodies Fit in the Pathogenesis of NMO?
Soluble axoplasm enriched from injured CNS axons reveals the early modulation of the actin cytoskeleton.
Systematic Review and Meta-Analysis of the Sero-Epidemiological Association between Epstein Barr Virus and Multiple Sclerosis.
Natalizumab-related anaphylactoid reactions in MS patients are associated with HLA class II alleles.
Multiple sclerosis in Pakistan: histocompatibility antigen composition and disability.
Network meta-analysis models to account for variability in treatment definitions: application to dose effects.
Perforin Expression by CD4+ Regulatory T Cells Increases at Multiple Sclerosis Relapse: Sex Differences.
The TASK1 channel inhibitor A293 shows efficacy in a mouse model of multiple sclerosis.
Do cortical lesions help us to distinguish MS from NMO?
Gemfibrozil, a lipid-lowering drug, increases myelin genes in human oligodendrocytes via peroxisome proliferator-activated receptor beta.
Neuropathic pruritus (itch) in neuromyelitis optica.
MRI measures should be a primary outcome endpoint in phase III randomised controlled trials in multiple sclerosis: Commentary.
The dynamics of finger tremor in multiple sclerosis is affected by whole body position.
Gait variability and disability in multiple sclerosis.
Immunomodulation of fucosyl-lactose and lacto-N-fucopentaose on mononuclear cells from multiple sclerosis and healthy subjects.
[2011: What's new in dysimmune neuropathies.]
Network-Based Multiple Sclerosis Pathway Analysis with GWAS Data from 15,000 Cases and 30,000 Controls.
Neurodegeneration in Autoimmune Optic Neuritis Is Associated with Altered APP Cleavage in Neurons and Up-Regulation of p53.
Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis.
The life extension protein Klotho enhances remyelination following cuprizone-induced demyelination
Optical coherence tomography and its use in optical neuritis and multiple sclerosis.
Any evident MRI T2-lesion activity should guide change of therapy in multiple sclerosis - Yes.
Balo's Concentric Sclerosis with Acute Presentation and Co-Existing Multiple Sclerosis-Typical Lesions on MRI.
CNS diseases and uveitis.
Pages
« first
‹ previous
…
198
199
200
201
202
203
204
205
206
…
next ›
last »